Banka BioLoo Q1 FY26-27: Profitability improves as order book and long-term water contracts shape the story

Banka BioLoo Limited’s Q1 FY26-27 investor presentation positions the company around a clear problem statement: sanitation and wastewater treatment remain deeply under-served, and the gap is widening with fast urbanisation. The company operates across two business lines, Banka Rail and Banka WaSH, and also highlights the scaling of its subsidiary, Megaliter Varunaa Pvt Ltd, as a long-tenure contracted portfolio with multi-year revenue recognition.

For the quarter ended 30 June 2026, the company reported standalone revenue of INR 16.40 crore, up from INR 13.61 crore in Q1 FY25-26. EBITDA increased to INR 1.51 crore from INR 1.03 crore, and PAT rose to INR 0.37 crore from INR 0.14 crore. The deck highlights YoY growth of 20.5 percent plus in revenue, 46.6 percent plus in EBITDA, and 162.3 percent plus in PAT, indicating that profitability expanded faster than topline in this quarter.

Two business lines anchored in operations and infrastructure

Banka Rail is described as a rail-focused services line, including bio-toilet operations and maintenance (AMOC), periodic overhauling and bogie upgradation (POH), quick watering systems (QWS), and coach upgradation and passenger amenity works. The presentation states that 25,000 plus railway systems are serviced daily across multiple railway zones.

Banka WaSH is positioned around EPC and operations for urban water and wastewater, including O&M and BOOT models for recycle and reuse projects. The deck also mentions bio-digesters through a DRDO partnership and faecal septage treatment plants. Operational impact metrics are presented, including 12 MLD plus faecal sludge treated and 4 plus billion used water treated, with a note that some figures were last reported for Q1 FY25-26 and should be confirmed if changed for Q1 FY26-27.

Financial summary (Standalone)

Order book: execution ahead of fresh booking in the quarter

The order book slide provides segment-wise data for Q1 FY26-27. Rail shows Q1 order booking of zero with an unexecuted order book (YTD) of INR 32 crore. WaSH shows Q1 booking of INR 4 crore with an unexecuted order book (YTD) of INR 50 crore. Total unexecuted order book is INR 82 crore.

The company also states that Q1 booking of INR 4.2 crore against INR 16.2 crore executed leaves an unexecuted order book of INR 82 crore, which it describes as multi-quarter visibility to rebuild revenue through FY26-27. This framing suggests the quarter saw strong conversion of existing orders, while the company will need continued order inflows to sustain momentum.

The presentation calls out notable wins: an order with Auro Infra in Hyderabad, expansion into Bangalore and Mumbai with wins involving Brigade, Reliance and RMZ, and multiple bio-toilet projects from construction clients and Grade-A developers in Hyderabad. The deck does not provide project sizes, timelines, or margin profiles for these wins, so the claims should be viewed as directional indicators of pipeline traction.

Megaliter Varunaa: a long-tenure contracted portfolio with stated net LTV of INR 122.1 crore

A central strategic highlight is Megaliter Varunaa Pvt Ltd, which the company presents as a scaling portfolio of water infrastructure projects. The deck shows cumulative expansion across plants, treatment capacity, and net lifetime value (LTV) from 2022-23 through YTD FY26-27.

By period, the presentation reports:

• 2022-23: 1 plant, 0.6 MLD, net LTV INR 5.2 crore
• 2023-24: 3 plants, 2.0 MLD, net LTV INR 12.9 crore
• 2024-25: 4 plants, 2.4 MLD, net LTV INR 20.2 crore
• 2025-26: 6 plants, 5.3 MLD, net LTV INR 49.4 crore
• YTD FY26-27: 15 plants, 11.7 MLD, net LTV INR 122.1 crore

The summary states 15 projects onboarded, plus 1 project at LOI stage, and treatment capacity of 11.7 MLD. Importantly, the deck says revenue from existing contracts is expected to be progressively recognized over 7 to 10-year contract tenures, positioning the current period as early in the revenue recognition cycle.

The presentation also notes that consolidated financials include revenue from the subsidiary as per Ind AS 110, while the quarter’s performance slide is explicitly labelled standalone. Investors comparing performance across periods would need to confirm which set of financials is being used for any specific analysis.

What the quarter suggests, and what remains to be validated

Q1 FY26-27 shows a clear improvement in profitability, with EBITDA and PAT growth outpacing revenue growth. The order book data indicates that execution in the quarter exceeded fresh booking, while management commentary emphasizes multi-quarter visibility from the remaining unexecuted order book of INR 82 crore.

Strategically, the subsidiary Megaliter Varunaa is presented as a long-term value driver. The deck’s stated net LTV of INR 122.1 crore and 7 to 10-year revenue recognition model provides a framework for understanding why near-term reported numbers may not fully reflect the scale of the contracted portfolio.

The key takeaway from the presentation is that Banka BioLoo is attempting to combine near-term execution across Rail and WaSH with a longer-duration contracted infrastructure base through Megaliter Varunaa. The next layer of confidence would come from more granular disclosure on segment profitability, contract terms, and how quickly the LTV base translates into recognized revenue and cash flows.